Please assess the completion status of the following clinical trial:

Trial Title: Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with cancer and confirmed pulmonary embolism (PE) or deep vein thrombosis (DVT) of the leg who have been treated for minimally 6 and maximally 12 months with therapeutic doses of anticoagulants, i.e. LMWH or VKA or a new anticoagulant in a trial~2. Written informed consent~3. Indication for long-term anticoagulant therapy (e.g. because of metastasized disease, chemotherapy)~Exclusion Criteria:~1. Legal age limitations (country specific), minimum age at least 18 years~2. Indications for anticoagulant therapy other than DVT or PE~3. Any contraindication listed in the local labeling of LMWH or VKA~4. Childbearing potential without proper contraceptive measures, pregnancy or breastfeeding~5. Life expectancy \<3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- vitamin K antagonists (Type: ACTIVE_COMPARATOR): None
- Low molecular weight heparin (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).